Takeda Pharmaceutical
16 hedge funds and large institutions have $62.4M invested in Takeda Pharmaceutical in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$5.17M |
| 2 |
KC
Kepos Capital
New York
|
+$2.78M |
| 3 |
FIA
FNY Investment Advisers
New York
|
+$1.21M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$207K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$43.5K |